Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Mar;48(3):223–225. doi: 10.1136/jcp.48.3.223

Iron metabolism and fungal infections in patients with haematological malignancies.

C Iglesias-Osma 1, L Gonzalez-Villaron 1, J F San Miguel 1, M D Caballero 1, L Vazquez 1, S de Castro 1
PMCID: PMC502449  PMID: 7730481

Abstract

AIM--To determine whether iron metabolism influences the incidence of systemic fungal infection in patients with haematological malignancies. METHODS--The study population comprised 74 patients who had undergone myeloablative chemotherapy. Systemic fungal infections were classified as confirmed (histological confirmation or characteristic septate hyphae) or possible (antibiotic resistant fever which resolved following administration of intravenous amphotericin B, together with either typical radiographic lesions or massive oropharyngeal candidiasis). Parameters of iron metabolism included serum iron concentrations, total iron binding capacity, serum transferrin, and ferritin concentrations and transferrin saturation values. RESULTS--Patients who developed a fungal infection had substantially increased transferrin saturation values and ferritin concentrations at diagnosis together with low serum transferrin and high serum iron concentrations. This profile was present in patients with a fungal infection regardless of the underlying haematological disorder. CONCLUSION--Increased transferrin saturation values and high ferritin concentrations may be additional risk factors for the development of systemic fungal infection in patients with haematological malignancies.

Full text

PDF
223

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe F., Inaba H., Katoh T., Hotchi M. Effects of iron and desferrioxamine on Rhizopus infection. Mycopathologia. 1990 May;110(2):87–91. doi: 10.1007/BF00446996. [DOI] [PubMed] [Google Scholar]
  2. Artis W. M., Patrusky E., Rastinejad F., Duncan R. L., Jr Fungistatic mechanism of human transferrin for Rhizopus oryzae and Trichophyton mentagrophytes: alternative to simple iron deprivation. Infect Immun. 1983 Sep;41(3):1269–1278. doi: 10.1128/iai.41.3.1269-1278.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aulbert E., Fromm H., Hornemann H. Ferritin bei akuten Leukämien. Die Serumferritinkonzentration als unspezifischer "Tumormarker" für die myeloische Leukämie M1 und M2. Med Klin (Munich) 1991 Jun 15;86(6):297–304. [PubMed] [Google Scholar]
  4. Bezwoda W. R., Derman D. P., Bothwell T. H., Baynes R., Hesdorffer C., MacPhail A. P. Serum ferritin and Hodgkin's disease. Scand J Haematol. 1985 Nov;35(5):505–510. doi: 10.1111/j.1600-0609.1985.tb02820.x. [DOI] [PubMed] [Google Scholar]
  5. CAROLINE L., TASCHDJIAN C. L., KOZINN P. J., SCHADE A. L. REVERSAL OF SERUM FUNGISTASIS BY ADDITION OF IRON. J Invest Dermatol. 1964 Jun;42:415–419. doi: 10.1038/jid.1964.90. [DOI] [PubMed] [Google Scholar]
  6. Caroline L., Rosner F., Kozinn P. J. Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia. Blood. 1969 Oct;34(4):441–451. [PubMed] [Google Scholar]
  7. Gordeuk V. R., Brittenham G. M. Bleomycin-reactive iron in patients with acute non-lymphocytic leukemia. FEBS Lett. 1992 Aug 10;308(1):4–6. doi: 10.1016/0014-5793(92)81037-m. [DOI] [PubMed] [Google Scholar]
  8. Holzberg M., Artis W. M. Hydroxamate siderophore production by opportunistic and systemic fungal pathogens. Infect Immun. 1983 Jun;40(3):1134–1139. doi: 10.1128/iai.40.3.1134-1139.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hunter R. L., Bennett B., Towns M., Vogler W. R. Transferrin in disease II: defects in the regulation of transferrin saturation with iron contribute to susceptibility to infection. Am J Clin Pathol. 1984 Jun;81(6):748–753. doi: 10.1093/ajcp/81.6.748. [DOI] [PubMed] [Google Scholar]
  10. Ismail A., Bedell G. W., Lupan D. M. Siderophore production by the pathogenic yeast, Candida albicans. Biochem Biophys Res Commun. 1985 Jul 31;130(2):885–891. doi: 10.1016/0006-291x(85)90499-1. [DOI] [PubMed] [Google Scholar]
  11. Jacobs A., Slater A., Whittaker J. A., Canellos G., Wiernik P. H. Serum ferritin concentration in untreated Hodgkin's disease. Br J Cancer. 1976 Aug;34(2):162–166. doi: 10.1038/bjc.1976.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jones P. A., Miller F. M., Worwood M., Jacobs A. Ferritinaemia in leukaemia and Hodgkin's disease. Br J Cancer. 1973 Mar;27(3):212–217. doi: 10.1038/bjc.1973.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kaneko T., Abe F., Ito M., Hotchi M., Yamada K., Okada Y. Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine. Acta Pathol Jpn. 1991 Jul;41(7):561–566. doi: 10.1111/j.1440-1827.1991.tb02521.x. [DOI] [PubMed] [Google Scholar]
  14. Karp J. E., Merz W. G. Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients. J Clin Oncol. 1986 Feb;4(2):216–220. doi: 10.1200/JCO.1986.4.2.216. [DOI] [PubMed] [Google Scholar]
  15. Oertel J., Schultz E., Korinth E., Heilhecker A. Die Ferritinkonzentration im Serum bei Patienten mit malignen Lymphomen. Klin Wochenschr. 1977 Nov 15;55(22):1109–1114. doi: 10.1007/BF01477938. [DOI] [PubMed] [Google Scholar]
  16. Parry D. H., Worwood M., Jacobs A. Serum ferritin in acute leukaemia at presentation and during remission. Br Med J. 1975 Feb 1;1(5952):245–247. doi: 10.1136/bmj.1.5952.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pootrakul P., Josephson B., Huebers H. A., Finch C. A. Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron. Blood. 1988 Apr;71(4):1120–1123. [PubMed] [Google Scholar]
  18. Tanaka M., Kato K. The measurement of ferritin in the leukemic blasts with a "sandwich" type enzyme immunoassay method. Cancer. 1983 Jan 1;51(1):61–64. doi: 10.1002/1097-0142(19830101)51:1<61::aid-cncr2820510115>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  19. White G. P., Worwood M., Parry D. H., Jacobs A. Ferritin synthesis in normal and leukaemic leukocytes. Nature. 1974 Aug 16;250(467):584–586. doi: 10.1038/250584a0. [DOI] [PubMed] [Google Scholar]
  20. Worwood M., Summers M., Miller F., Jacobs A., Whittaker J. A. Ferritin in blood cells from normal subjects and patients with leukaemia. Br J Haematol. 1974 Sep;28(1):27–35. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES